Skip to main content
Clinical Trials/NL-OMON47887
NL-OMON47887
Completed
Not Applicable

Translating neuroimaging findings from research into clinical practice (PSYSCAN): Clinical High Risk - PSYSCAN - UHR

Institute of Psychiatry, King's College, London0 sites74 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
high risk of psychosis
Sponsor
Institute of Psychiatry, King's College, London
Enrollment
74
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Institute of Psychiatry, King's College, London

Eligibility Criteria

Inclusion Criteria

  • \* 16\-40 years old
  • \* Written informed consent of subjects aged 18 to 40 years
  • \* Written informed consent of parents and/or legal guardians for subjects aged
  • 16 or 17, in
  • addition to assent from the minor subject, following local laws and regulations
  • Participants at high risk of psychosis will be evaluated using a quantitative
  • clinical tool that
  • \* Inclusion into one of three groups as assessed by the Comprehensive
  • Assessment of At\-Risk Mental States (CAARMS version 2006\):
  • i) vulnerability group,

Exclusion Criteria

  • \* Any previous neurosurgery or neurological disorder, including epilepsy
  • \* History of head injury resulting in unconsciousness lasting at least 1 hour
  • \* Pregnancy
  • \* Any contraindications for MRI
  • \* Refusing to have blood drawn and/or MRI performed
  • \* Subject is unable to fully comprehend the purpose of the study or make a
  • decision whether or not to participate
  • \* Estimate of IQ \< 70
  • \* Antipsychotic medication for \> 30 days (cumulative number of days) in the 3
  • before the baseline assessments (including self\-ratings and screening

Outcomes

Primary Outcomes

Not specified

Similar Trials